Literature DB >> 25667028

Pyloric sphincter therapy: botulinum toxin, stents, and pyloromyotomy.

John O Clarke1, William J Snape2.   

Abstract

Gastroparesis is a syndrome characterized by delayed gastric emptying with associated symptoms. Gastric emptying is a complex process and pyloric dysfunction may play a key role in select subsets of patients with gastroparesis. Diagnostic tests to measure pyloric physiology are now available and have the potential to be more widely used in clinical practice. Targeted therapies including botulinum toxin, transpyloric stent placement, surgical pyloroplasty and endoscopic pyloromyotomy have been developed. Data are emerging regarding efficacy and durability, but these therapies may play a prominent role in select patients with gastroparesis and pyloric dysfunction.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Botulinum toxin; Gastroparesis; Impedance planimetry; Pyloric stent; Pyloromyotomy; Pyloroplasty

Mesh：

Substances：

Year:  2015        PMID： 25667028     DOI： 10.1016/j.gtc.2014.11.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  8 in total

1.  Fluoroscopy-guided gastric peroral endoscopic pyloromyotomy (G-POEM): a more reliable and efficient method for treatment of refractory gastroparesis.

Authors:  H B Xue; H Z Fan; X M Meng; S Cristofaro; P Mekaroonkamol; S Dacha; L Y Li; X L Fu; S H Zhan; Q Cai
Journal:  Surg Endosc       Date:  2017-04-13       Impact factor: 4.584

2.  How I Do It: Per-Oral Pyloromyotomy (POP).

Authors:  Matthew T Allemang; Andrew T Strong; Ivy N Haskins; John Rodriguez; Jeffrey L Ponsky; Matthew Kroh
Journal:  J Gastrointest Surg       Date:  2017-07-27       Impact factor: 3.452

Review 3.  Endoscopic Therapies for Gastroparesis.

Authors:  Andrew Su; Jeffrey L Conklin; Alireza Sedarat
Journal:  Curr Gastroenterol Rep       Date:  2018-04-23

Review 4.  Chronic Unexplained Nausea and Vomiting or Gastric Neuromuscular Dysfunction (GND)? An Update on Nomenclature, Pathophysiology and Treatment, and Relationship to Gastroparesis.

Authors:  Kimberly N Harer; Pankaj J Pasricha
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

Review 5.  Peroral endoscopic pyloromyotomy for gastroparesis: a systematic review and meta-analysis.

Authors:  Karime Lucas Uemura; Dalton Chaves; Wanderley M Bernardo; Ricardo Sato Uemura; Diogo Turiani Hourneaux de Moura; Eduardo Guimarães Hourneaux de Moura
Journal:  Endosc Int Open       Date:  2020-06-16

6.  Endoscopic pyloromyotomy for the treatment of severe and refractory gastroparesis: a pilot, randomised, sham-controlled trial.

Authors:  Jan Martinek; Rastislav Hustak; Jan Mares; Zuzana Vackova; Julius Spicak; Eva Kieslichova; Marie Buncova; Daniel Pohl; Sunil Amin; Jan Tack
Journal:  Gut       Date:  2022-04-25       Impact factor: 31.793

7.  Proof of concept: short-term non-invasive cervical vagus nerve stimulation in patients with drug-refractory gastroparesis.

Authors:  Emma Paulon; Despoina Nastou; Francesca Jaboli; Juana Marin; Eric Liebler; Owen Epstein
Journal:  Frontline Gastroenterol       Date:  2017-05-24

Review 8.  Gastric Peroral Endoscopic Myotomy.

Authors:  Hyunsoo Chung; Mouen A Khashab
Journal:  Clin Endosc       Date:  2018-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.